MRK
Merck & Co., Inc. · Healthcare · Drug Manufacturers - General
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q2 2024
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | 0 | 1.60B | $205.60B | +4 | −3 |
| Q1 2026 | 185 | +1 | 1.56B | $186.85B | +3 | −3 |
| Q4 2025 | 183 | 0 | 1.68B | $176.48B | +1 | — |
| Q3 2025 | 27 | 0 | 972.48M | $81.66B | +1 | −2 |
| Q2 2025 | 25 | 0 | 887.01M | $70.29B | +1 | −1 |
| Q1 2025 | 22 | -1 | 386.62M | $34.78B | — | −1 |
| Q4 2024 | 23 | -1 | 374.82M | $37.37B | — | −1 |
| Q3 2024 | 23 | +1 | 256.79M | $29.14B | +1 | — |
| Q2 2024 | 22 | — | 256.16M | $31.70B | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 72.48M | — | $8.97B | 1.6% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passif) | 57.02M | — | $7.04B | 0.6% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passif) | 57.02M | — | $7.04B | 0.6% | n/c | 1 | SEC ↗ |
| 12 | Norges Bank ✦ (passif) | 33.81M | — | $4.19B | 0.6% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 24.73M | — | $3.06B | 0.4% | n/c | 1 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 24.73M | — | $3.06B | 0.4% | n/c | 1 | SEC ↗ |
| 15 | Capital World Investors ✦ | 15.27M | — | $1.89B | 0.3% | n/c | 1 | SEC ↗ |
| 16 | Fisher Asset Management ✦ | 14.27M | — | $1.77B | 0.8% | n/c | 1 | SEC ↗ |
| 17 | Millennium Management ✦ | 9.59M | — | $1.19B | 1.0% | n/c | 1 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 8.24M | — | $1.02B | 1.0% | n/c | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 8.24M | — | $1.02B | 1.0% | n/c | 1 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 6.21M | — | $768.45M | 0.7% | n/c | 1 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 3.17M | — | $392.59M | 0.7% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 2.58M | — | $319.92M | 0.5% | n/c | 1 | SEC ↗ |
| 23 | Marshall Wace ✦ | 2.58M | — | $319.92M | 0.5% | n/c | 1 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.38M | — | $294.49M | 0.4% | n/c | 1 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 2.38M | — | $294.49M | 0.4% | n/c | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 2.21M | — | $273.76M | 0.4% | n/c | 1 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 2.21M | — | $273.76M | 0.4% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 2.21M | — | $273.76M | 0.4% | n/c | 1 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 2.21M | — | $273.76M | 0.4% | n/c | 1 | SEC ↗ |
| 30 | Bridgewater Associates ✦ | 1.80M | — | $223.09M | 1.2% | n/c | 1 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 1.48M | — | $183.61M | 0.4% | n/c | 1 | SEC ↗ |
| 32 | Soros Fund Management ✦ | 300.00K | — | $37.14M | 1.1% | n/c | 1 | SEC ↗ |
| 33 | Fairfax Financial ✦ | 172.90K | — | $21.39M | 1.8% | n/c | 1 | SEC ↗ |
| 34 | Dodge & Cox ✦ | 158.88K | — | $19.67M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Gotham Asset Management ✦ | 137.65K | — | $17.04M | 0.2% | n/c | 1 | SEC ↗ |
| 36 | GAMCO Investors ✦ | 76.77K | — | $9.50M | 0.1% | n/c | 1 | SEC ↗ |
| 37 | PRIMECAP Management ✦ | 72.80K | — | $9.01M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Renaissance Technologies ✦ | 4.92K | — | $609,688 | 0.0% | n/c | 1 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Aucun nouvel acheteur suivi ce trimestre. |
Sorti(e)
| Aucune sortie suivie ce trimestre. |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 3,742 détenteurs, 1.88B actions, $215.80B déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.
Achats sur le marché libre (P)
Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.
Ventes sur le marché libre (S)
Officer · 10.00K act. · $1.35M
Officer · 80.31K act. · $10.72M
Officer · 11.10K act. · $1.46M
Officer · 600 act. · $79,222
Officer · 5.43K act. · $718,261
Officer · 7.41K act. · $973,165
Officer · 20.78K act. · $2.71M
Officer · 805 act. · $105,472
Officer · 4.95K act. · $643,993
Officer · 300 act. · $39,307
Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie